Abstract:Major depressive disorder is often characterized by changes in the structure and function of the brain, which are influenced by modifications in gene expression profiles. How the depression-related genes work together within the scope of time and space to cause pathological changes remains unclear. By integrating the brain-wide gene expression data and imaging data in major depressive disorder, we identified gene signatures of major depressive disorder and explored their temporal-spatial expression specificity, network properties, function annotations and sex differences systematically. Based on correlation analysis with permutation testing, we found 345 depression-related genes significantly correlated with functional and structural alteration of brain images in major depressive disorder and separated them by directional effects. The genes with negative effect for grey matter density and positive effect for functional indices are enriched in downregulated genes in the post-mortem brain samples of patients with depression and risk genes identified by genome-wide association studies than genes with positive effect for grey matter density and negative effect for functional indices and control genes, confirming their potential association with major depressive disorder. By introducing a parameter of dispersion measure on the gene expression data of developing human brains, we revealed higher spatial specificity and lower temporal specificity of depression-related genes than control genes. Meanwhile, we found depression-related genes tend to be more highly expressed in females than males, which may contribute to the difference in incidence rate between male and female patients. In general, we found the genes with negative effect have lower network degree, more specialized function, higher spatial specificity, lower temporal specificity and more sex differences than genes with positive effect, indicating they may play different roles in the occurrence and development of major depressive disorder. These findings can enhance the understanding of molecular mechanisms underlying major depressive disorder and help develop tailored diagnostic and treatment strategies for patients of depression of different sex.

Different stress-related gene expression in depression and suicide

Prefrontal Alterations in GABAergic and Glutamatergic Gene Expression in Relation to Depression and Suicide.

Ndt_a_219962 2893..2900

Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity

Integrative analyses of scRNA-seq, bulk mRNA-seq, and DNA methylation profiling in depressed suicide brain tissues

Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide

Network-based approach to identify molecular signatures in the brains of depressed suicides

Changes in glial gene expression in the prefrontal cortex in relation to major depressive disorder, suicide and psychotic features

Prefrontal changes in the glutamate-glutamine cycle and neuronal/glial glutamate transporters in depression with and without suicide

Brain transcriptomic signatures for mood disorders and suicide phenotypes: an anterior insula and subgenual ACC network postmortem study

Gene expression and brain imaging association study reveals gene signatures in major depressive disorder

Integrative transcriptome- and DNA methylation analysis of brain tissue from the temporal pole in suicide decedents and their controls

A Unique Gene Expression Signature Associated with Serotonin 2C Receptor RNA Editing in the Prefrontal Cortex and Altered in Suicide.

Brain and blood transcriptome profiles delineate common genetic pathways across suicidal ideation and suicide

Altered transcriptomes, cell type proportions, and dendritic spine morphology in hippocampus of suicide decedents

Genome-wide methylome-based molecular pathologies associated with depression and suicide

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Differential Gene Expression in Patients with Subsyndromal Symptomatic Depression and Major Depressive Disorder

Transcriptomics and sequencing analysis of gene expression profiling for major depressive disorder

Brain 5-HT1 binding sites in depressed suicides

Gene Expression Signatures Differentiating Major Depressive Disorder from Subsyndromal Symptomatic Depression.